Follicle Stimulating Hormones Market Size, Share & Industry Analysis, By Type (Recombinant FSH, Urinary-derived FSH, and FSH Combination Products), By Product (Follitropin Alfa, Follitropin Beta, Urofollitropin, and Menotropins), By Application (Controlled Ovarian Stimulation for IVF/ICSI, Ovulation Induction, and Male Infertility/Spermatogenesis Induction), By Patient Group (Male and Female), By Route of Administration (Subcutaneous and Intramuscular), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: September 02, 2026 | Format: PDF | Report ID: FBI111656

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 6.37% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Type, Product, Application, Patient Group, Route of Administration, Distribution Channel, and Region
By Type	Recombinant FSH Urinary-derived FSH FSH Combination Products Others
By Product	Follitropin Alfa Follitropin Beta Urofollitropin Menotropins/hMG Corifollitropin Alfa Others
By Application	Controlled Ovarian Stimulation for IVF/ICSI Ovulation Induction Male Infertility/Spermatogenesis Induction Fertility Preservation Others
By Patient Group	Male Female
By Route of Administration	Subcutaneous Intramuscular
By Distribution Channel	Hospital Pharmacies Retail Pharmacies & Drug Stores Online Pharmacies
By Region	North America (By Type, Product, Application, Patient Group, Route of Administration, Distribution Channel, and Country) U.S. Canada Europe (By Type, Product, Application, Patient Group, Route of Administration, Distribution Channel, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Type, Product, Application, Patient Group, Route of Administration, Distribution Channel, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Type, Product, Application, Patient Group, Route of Administration, Distribution Channel, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Type, Product, Application, Patient Group, Route of Administration, Distribution Channel, and Country/Sub-region) GCC South Africa Rest of Middle East & Africa